Brodimoprim is a structural derivative of trimethoprim where the 4-methoxy group is replaced with a bromine atom. It is a dihydrofolate reductase inhibitor used as a pharmaceutical raw material.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 56518-41-3
Trimethoprim
pharmaceutical raw material
7-keto-dehydroepiandrosterone
pharmaceutical raw material
5α-Dihydroprogesterone
pharmaceutical raw material
Cefmetazole
pharmaceutical raw material
Cefmetazole sodium
pharmaceutical raw material
5-(3,4-Dimethoxybenzyl)pyrimidine-2,4-diamine hydrochloride
pharmaceutical raw material
Diaveridine
pharmaceutical raw material
5-({3,5-Dimethoxy-4-[(²H₃)methyloxy]phenyl}methyl)pyrimidine-2,4-diamine
research compound
5-[(4-bromo-3,5-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine
BFCRRLMMHNLSCP-UHFFFAOYSA-N
COC1=CC(=CC(=C1Br)OC)CC2=CN=C(N=C2N)N